Emory Tightens Up Conflct of Interest Rules at Med School
Emory University School of Medicine announced a toughened ethics policy Wednesday to better govern faculty and students in their financial dealings with outside industry.
Late last year, Emory became the focus of an ethics investigation by Congress and the National Institutes of Health. The NIH froze funds for a $9.3 million project.
Dr. Charles Nemeroff, the former chairman of Emory’s psychiatric and behavioral sciences department and an international expert on depression, was the central figure in the investigation. Congressional investigators said Nemeroff received $2.8 million in consulting fees from companies whose drugs he was evaluating and he failed to report a third of that amount to the university.
Emory also said Nemeroff earned $800,000 in speaking fees for appearing at industry events for one company.
Attempts to reach Nemeroff, who left the department chairmanship late last year but remains a professor at Emory, and Medical School Dean Thomas Lawley were unsuccessful.
The last I heard, Dr. Cerra was in no hurry to get this problem taken care of at the University of Minnesota, where we have been, supposedly, working on it for a couple of years...